Overview

Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well ixabepilone works in treating patients with locally advanced or metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute (NCI)